scholarly journals Strong Cortical and Spinal Cord Transduction After AAV7 and AAV9 Delivery into the Cerebrospinal Fluid of Nonhuman Primates

2013 ◽  
Vol 24 (5) ◽  
pp. 526-532 ◽  
Author(s):  
Lluis Samaranch ◽  
Ernesto A. Salegio ◽  
Waldy San Sebastian ◽  
Adrian P. Kells ◽  
John R. Bringas ◽  
...  
1994 ◽  
Vol 58 (1) ◽  
pp. 112-115 ◽  
Author(s):  
Shigeru Kazama ◽  
Yoshihiko Masaki ◽  
Shigeyoshi Maruyama ◽  
Akira Ishihara

1988 ◽  
Vol 13 (3) ◽  
pp. 353-357 ◽  
Author(s):  
Steven E. Shelton ◽  
Ned H. Kalin ◽  
John P. Gluck ◽  
Michael F. Keresztury ◽  
Vicki A. Schneider ◽  
...  

2000 ◽  
Vol 70 (1) ◽  
pp. 222-227 ◽  
Author(s):  
Sven A Meylaerts ◽  
Cor J Kalkman ◽  
Peter de Haan ◽  
Marjolein Porsius ◽  
Michael J.H.M Jacobs

1998 ◽  
Vol 41 (6) ◽  
pp. 464-468 ◽  
Author(s):  
Susan M. Blaney ◽  
Chris Takimoto ◽  
Daryl J. Murry ◽  
Nancy Kuttesch ◽  
Cynthia McCully ◽  
...  

1989 ◽  
Vol 3 (3) ◽  
pp. 247-252 ◽  
Author(s):  
S. J. Wimalawansa ◽  
H. R. Morris ◽  
I. Maclntyre

ABSTRACT The presence of both α- and β-calcitonin gene-related peptide (CGRP) was demonstrated by oxidation and by CNBr cleavage in extracts of plasma, cerebrospinal fluid and spinal cord in man. This was achieved by the use of both CNBr cleavage and oxidation of the methionine residue present in the human β-CGRP molecule. This study demonstrates that around 50% of CGRP immunoreactivity in plasma, cerebrospinal fluid and spinal cord is not α-CGRP, but corresponds to β-CGRP-like activity. Furthermore, experiments with CNBr also suggest the presence of another methionine-containing CGRP-like peptide in all three extracts.


Sign in / Sign up

Export Citation Format

Share Document